Previous Article in Journal
Abstracts of the 3rd International Electronic Conference on Microbiology
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Proceeding Paper

Detection and Species Distribution of Fungal Pathogens Associated with Otomycosis in a Tertiary Health Center in Kano, Nigeria †

by
Khadija Muhammad Kawu
1,
Muhammad Ibrahim Getso
1,*,
Taysir Ramadan
1,
Alhassan Abdullahi Sharif
1,
Kanishka Hrishi Das
2,
Al-Mukhtar Yahuza Adamu
1 and
Mansur Aliyu
1
1
Department of Medical Microbiology and Parasitology, College of Health Sciences, Bayero University Kano, Kano P.M.B. 3011, Nigeria
2
Department of Allied Health Science, Chitkara School of Health Sciences, Chitkara University, Rajpura 140401, Punjab, India
*
Author to whom correspondence should be addressed.
Presented at the 3rd International Electronic Conference on Microbiology, 1–3 April 2025; Available online: https://sciforum.net/event/ECM2025.
Biol. Life Sci. Forum 2025, 46(1), 4; https://doi.org/10.3390/blsf2025046004
Published: 22 August 2025

Abstract

Otomycosis is the commonest cause of otitis externa seen in otorhinolaryngology clinics, especially in tropical and subtropical regions of the world. Diagnosis is usually made clinically and confirmed by laboratory identification of fungal elements. We conducted a cross-sectional and hospital-based epidemiological study that aimed to determine the prevalence, distribution and antifungal susceptibility profile of common aetiologic agents of otomycosis in Kano, northwestern Nigeria. We collected clinical samples from 300 patients who presented with symptoms of external ear infection, out of which 117 subjects (39.0%) were mycologically positive. Aspergillus species were the predominant isolate, with 90 (77.0%), followed by Candida species at 27 (23.0%). Otomycosis accounts for 39% of otitis externa seen in our center, mostly presenting with pruritus and otalgia. Raising the awareness of the general population to the predisposing factors may significantly reduce the incidence of otomycosis.

1. Introduction

Otitis externa is estimated to account for 5–20% of all ear-related visits to Ear, Nose, and Throat (ENT) clinics, of which 10–25% have been attributed to otomycosis—a superficial fungal infection of the ear, involving the external auditory canal (EAC), auricle and even tympanic membrane. It usually manifests as pruritus, aural fullness, otalgia, otorrhea, and varied levels of hearing loss [1,2,3]. The infection is commonly unilateral, with the bilateral form being observed frequently among immunocompromised patients [4]. Diagnosis of otomycosis is challenging as it frequently relies on the patient’s history of exposure to risk factors, otoscopic examination and certain clinical presentations [5]. The current study aimed to evaluate the frequency and distribution of fungal pathogens associated with otomycosis among patients attending ENT clinics in a tertiary health center in Kano, Nigeria.

2. Materials and Methods

This was a prospective study conducted in the Department of Medical Microbiology and Parasitology, Bayero University Kano, Nigeria, from January to June 2024. A total of 300 patients with a clinical diagnosis of otitis externa were enrolled from the otorhinolaryngology clinic, ENT Department of Aminu Kano Teaching Hospital. Ethical approval was obtained from the research ethical committee of Aminu Kano Teaching Hospital, Kano (NHREC/28/01/2020/AKTH/EC/3748). Consent or assent was also obtained from the study participants before commencement of the research.
Two swab samples were taken from the EAC of each case. The first swab was evaluated for microscopy using potassium hydroxide (KOH) mount and Gram staining. The second swab was subjected to fungal culture on Sarbouraud’s dextrose agar with chloramphenicol at 25 °C and 37 °C. Isolates were identified using conventional mycological examinations. In addition, isolates with atypical morphology were identified to species level by PCR sequencing of the ribosomal DNA (rDNA) internal transcribed spacer (ITS). For yeast isolates, yeast-specific universal primers ITS1 (5′-TCC GTA GGT GAA CCT GCG G-3′) and ITS4 (5′-TCC TCC GCT TAT TGA TAT GC-3′) were used [3], and for Aspergillus species, the β-tubulin gene was amplified and sequenced using the primers Bt2a (5′-GGT AAC CAA ATC GGT GCT GCT TTC-3′) and Bt2b (5′-ACC CTC AGT GTA GTG ACC CTT GGC-3′) [6].

3. Results

Out of 300 patients, 117 subjects (39.0%) were mycologically positive; the rest were negative. Females 207 (69.0%) and individuals within the age group ≤ 10 years (44.3%) were the most affected. There is a statistically significant relationship between otomycosis and different age groups (p = 0.045). Most patients had unilateral presentation of otomycosis (285 (95.0%)), with predominant right ear infection in 215 (71.7%).
The table below (Table 1) shows a comparison of direct microscopy and culture results of the study participants. According to the findings, 35.3% of the samples were positive by direct microscopy and 39% were culture-positive. Interestingly, there was a statistically significant difference in the diagnostic yields between the two tests (p < 0.01).
The species distribution of the etiologic agents of otomycoses varied between yeast and mold. Whereas non-albicans candida was predominant in the yeast isolates, with Candida parapsilosis in the lead (Figure 1), Aspergillus species was the only mold isolated with a predominance of Aspergillus flavus. Sequences of those isolates identified using ITS PCR-sequencing were deposited into NCBI database, and their respective accession numbers are shown in Table 2.

4. Discussion

The occurrence of otomycosis varies with geographic location and is primarily influenced by environmental conditions. It is more prevalent in the tropics and seen in all ages. In this study, otomycosis accounted for 39.0% of otitis externa seen in our centers, which was comparable to the finding highlighted by earlier studies. The prevalence is similar to the 39.6% obtained in a study conducted in Ibadan, Western Nigeria [7], but lower than the 78.4% reported from in Lagos [5], that lies within the same western region.
Unilateral involvement was seen in 95% in our study, which correlates with another study in India, reported by Aggarwal and Jaiswal (2019), in which unilateral involvement was 92% [8]. Similarly, a study undertaken in Ekiti, Nigeria [1], reported unilateral ear infection in 95% of the subjects examined.
The current study revealed that the majority (44.3%) of the patients affected belonged to the age group of 0 and 10 years, followed by those in the age bracket 11 to 20 years, amounting to 24.0%. This is consistent with the age groups observed by other researchers from Sokoto, northern Nigeria [9], and Lagos, south-western Nigeria [5]. Similarly, in western Nigeria, Onotai and Osuji (2016) recorded a peak prevalence (30.7%) in the age groups of 1–10 years [10]. The predominance of this pediatric age with otomycosis could be a result of spending more time outdoors and being more exposed to fungal spores. On the other hand, other studies revealed a predominance of patients with otomycosis among young females of ages 12–30 years [11], 11–20 years [12] and 21–30 years [13]. Thus, otomycosis is a disease of all ages. In our study, there was a statistically significant difference between age group and otomycosis.
The current study revealed that Aspergillus was the most commonly isolated species (77%), followed by Candida (23%). Previous studies observed the same pattern [11,13]. The predominant Aspergillus spp. was Aspergillus flavus, which accounted for 34.2%, followed by Aspergillus niger 19.7%. This is in tandem with previous reports in which Aspergillus flavus predominates [5], but in disagreement to other studies [11,12,13,14] that reported Aspergillus niger as the predominantly isolated pathogen. The predominant Candida species was Candida parapsilosis, which correlates with a study conducted in Indonesia [15]. A more recent systematic review reported Aspergillus niger and Candida parapsilosis as the leading etiologies of otomycosis [16].

5. Conclusions

Otomycosis accounts for 39% of otitis externa seen in our center, mostly presenting with pruritus and otalgia. The spectrum of fungal pathogens isolated includes Aspergillus and Candida species. Aspergillus flavus and Candida parapsilosis were the most common etiologic agents isolated. Raising awareness among the general population to the predisposing factors may significantly reduce the incidence of otomycosis.

Author Contributions

Conceptualization, K.M.K., M.I.G. and T.R.; methodology, K.M.K., M.I.G. and K.H.D.; formal analysis, A.A.S.; data curation, K.M.K.; writing—original draft preparation, K.M.K.; writing—review and editing, M.I.G. and M.A.; supervision, M.I.G. and T.R.; project administration, A.-M.Y.A. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

This study was conducted in accordance with the Declaration of Helsinki, and approved by the Research Ethical Committee of Aminu Kano Teaching Hospital (NHREC/28/01/2020/AKTH/EC/3748) and that of the Ministry of Health, with approval number NHREC/17/03/2018 and dated 11 December 2023.

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Acknowledgments

We acknowledge the support given to us by the administrative and technical staff of Aminu Kano Teaching Hospital, Kano State Ministry of Health and Department of Medical microbiology and Parasitology, Bayero University, Kano, Nigeria.

Conflicts of Interest

The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

References

  1. Aremu, S.K.; Adewoye, K.R.; Ibrahim, T. A prospective analysis of otomycosis in a tertiary care hospital. Int. J. Trop. Dis. 2020, 3, 1–8. [Google Scholar] [CrossRef]
  2. Samorekar, A.V.; N, S.S.; Kumar, M.; Kumar, S.; SA, L. Clinical presentation and fungal species distribution in otomycosis in a tertiary care hospital. MGM J. Med. Sci. 2023, 10, 56–62. [Google Scholar] [CrossRef]
  3. Sarwestani, H.K.; Ghazvini, R.D.; Hashemi, S.J.; Rezaie, S.; Shoar, M.G.; Mahmoudi, S.; Elahi, M.; Tajdini, A. Investigation of etiologic agents and clinical presentations of otomycosis at a tertiary referral center in Tehran, Iran. Iran. J. Public Health 2019, 48, 331–337. [Google Scholar] [CrossRef]
  4. Bojanović, M.; Stalević, M.; Arsić-Arsenijević, V.; Ignjatović, A.; Ranđelović, M.; Golubović, M.; Živković-Marinkov, E.; Koraćević, G.; Stamenković, B.; Otašević, S. Etiology, Predisposing Factors, Clinical Features and Diagnostic Procedure of Otomycosis: A Literature Review. J. Fungi 2023, 9, 662. [Google Scholar] [CrossRef] [PubMed]
  5. Asoegwu, C.N.; Oladele, R.O.; Kanu, O.O.; Peters, R.F.; Nwawolo, C.C. Clinical and microbiological profile of otomycosis in Lagos, Nigeria. Niger. Postgrad. Med. J. 2023, 30, 132–136. [Google Scholar] [CrossRef] [PubMed]
  6. Aboutalebian, S.; Mahmoudi, S.; Mirhendi, H.; Okhovat, A.; Abtahi, H.; Chabavizadeh, J. Molecular epidemiology of otomycosis in Isfahan revealed a large diversity in causative agents. J. Med. Microbiol. 2019, 68, 918–923. [Google Scholar] [CrossRef] [PubMed]
  7. Fayemiwo, S.A.; Ogunleye, V.O.; Adeosun, A.A.; Bakare, R.A. Prevalence of otomycosis in Ibadan: A review of laboratory reports. Afr. J. Med. Med. Sci. 2010, 39, 219–222. [Google Scholar] [PubMed]
  8. Aggarwal, S.K.; Jaiswal, K. Fungal profile and its characteristics in patients of otomycosis—A prospective study. Natl. J. Lab. Med. 2019, 8, MO04–MO07. [Google Scholar] [CrossRef]
  9. Ashcroft, O.F.; Airauhi, U.; Muhammad, A.; Mohammed, K.; Haruna, B.A.; Iduh, M.U.; Bunza, N.M.; Nataala, S.U.; Yusuf, A.A. Identification and Characterization of Fungal Isolates Incriminated In The Infection of The Middle Ear Among Patients Attending Otorhinolaryngology (E.N.T) Clinic In Specialist Hospital Sokoto. BJMLS 2019, 4, 19–26. [Google Scholar]
  10. Onotai, L.; Osuji, A.E. Otomycosis: Management challenges and outcomes in a resource poor country. Niger. Health J. 2016, 16, 219. [Google Scholar]
  11. Alam, I.; Gupta, R.K.; Bhargava, A.; Faiz, S.M.; Srivastava, S.; Haider, F.; Singh, A.; Sharma, H. A study of clinico-mycological profile and treatment of primary otomycosis. Asian J. Med. Sci. 2023, 14, 133–138. [Google Scholar] [CrossRef]
  12. Yabo, U.S.; Robert, I.K.; Muhammad, Y.; Giro, A.M. Otomycosis in Patients Attending a Tertiary Health-care Institution in Sokoto, Northwestern Nigeria. Indian J. Otol. 2024, 30, 86–89. [Google Scholar] [CrossRef]
  13. Asok, S.; Cml, R.; Km, V.; Iqbal, S. A study on mycology spectrum with aetiopathological factors and its management in otomycosis. Int. J. Sci. Res. Arch. 2024, 11, 1916–1918. [Google Scholar] [CrossRef]
  14. Rehamnia, Y.; Lebied, A.; Dehan, S.; Merad, Y. Prevalence of otomycosis in Constantine, Algeria: A cross-sectional study of two months. J. Curr. Med. Res. Opin. 2024, 7, 2010–2016. [Google Scholar]
  15. Darmawan, A.B.; Krisniawati, N.; Widhi, A.P.K.N.; Hestiyani, R.A.N.; Kurniawan, D.W.; Darmayan, B.J. Etiology and Antifungal Sensitivity Test in Otomycosis Caused by Candida sp. Maj. Kedokt. Bdg. 2023, 55, 220–226. [Google Scholar] [CrossRef]
  16. Nazari, T.; Peymaeei, F.; Mirsaid, R.G.; Ahmadnezhad, R.S.; Shalmani, A.B.; Mahmoudi, S. Otomycosis: A systematic review and meta-analysis of prevalence and causative agents in the era of molecular diagnostics. BMC Infect. Dis. 2025, 25, 544. [Google Scholar] [CrossRef]
Figure 1. Species distribution of the isolates.
Figure 1. Species distribution of the isolates.
Blsf 46 00004 g001
Table 1. Results of direct microscopy (10% KOH) and culture.
Table 1. Results of direct microscopy (10% KOH) and culture.
MethodsCulture +ve (n, %)Culture −ve (n, %)Total (n, %)p-Value
Direct microscopy +ve (n, %)98 (32.7)8 (2.7)106 (35.3)<0.001
Direct microscopy −ve (n, %)19 (6.3)175 (58.3)194 (64.7)
Total (n, %)117 (39.0)183 (61.0)300 (100)
KOH = Potassium hydroxide; +ve = positive; −ve = negative.
Table 2. Accession numbers of the isolates identified using ITS sequencing.
Table 2. Accession numbers of the isolates identified using ITS sequencing.
Yeast StrainsAccession No.Mold StrainsAccession No.
Candida albicansPX057625Aspergillus flavusPV999229
C. tropicalisPX057626A. fumigatusPX057078
C. kruseiPX057628A. terreusPX057079
C. glabrataPX056818A. fumigatusPX056813
C. parapsilosisPX056819A. nigerPX057422
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Kawu, K.M.; Getso, M.I.; Ramadan, T.; Sharif, A.A.; Das, K.H.; Adamu, A.-M.Y.; Aliyu, M. Detection and Species Distribution of Fungal Pathogens Associated with Otomycosis in a Tertiary Health Center in Kano, Nigeria. Biol. Life Sci. Forum 2025, 46, 4. https://doi.org/10.3390/blsf2025046004

AMA Style

Kawu KM, Getso MI, Ramadan T, Sharif AA, Das KH, Adamu A-MY, Aliyu M. Detection and Species Distribution of Fungal Pathogens Associated with Otomycosis in a Tertiary Health Center in Kano, Nigeria. Biology and Life Sciences Forum. 2025; 46(1):4. https://doi.org/10.3390/blsf2025046004

Chicago/Turabian Style

Kawu, Khadija Muhammad, Muhammad Ibrahim Getso, Taysir Ramadan, Alhassan Abdullahi Sharif, Kanishka Hrishi Das, Al-Mukhtar Yahuza Adamu, and Mansur Aliyu. 2025. "Detection and Species Distribution of Fungal Pathogens Associated with Otomycosis in a Tertiary Health Center in Kano, Nigeria" Biology and Life Sciences Forum 46, no. 1: 4. https://doi.org/10.3390/blsf2025046004

APA Style

Kawu, K. M., Getso, M. I., Ramadan, T., Sharif, A. A., Das, K. H., Adamu, A.-M. Y., & Aliyu, M. (2025). Detection and Species Distribution of Fungal Pathogens Associated with Otomycosis in a Tertiary Health Center in Kano, Nigeria. Biology and Life Sciences Forum, 46(1), 4. https://doi.org/10.3390/blsf2025046004

Article Metrics

Back to TopTop